FEBU
Fellow of the European Board of Urology
Prostate Cancer Risk StratificationEnglish
Exam overviewPractice session
A 69-year-old man has newly diagnosed prostate cancer with PSA 28 ng/mL, cT2c disease, and biopsy ISUP Grade Group 2. He has no symptoms of metastasis. Which statement about risk grouping and staging is most appropriate?
Loading your practice session…